IHH Healthcare Berhad 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Prem Kumar Nair

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	1.1yrs
CEO 소유권	n/a
경영진 평균 재임 기간	2.8yrs
이사회 평균 재임 기간	1.8yrs

최근 관리 업데이트

Recent updates

CEO

Prem Kumar Nair (63 yo)

1.1yrs

테뉴어

Dr. Prem Kumar Nair serves as Non-Executive Director of Parkway Trust Management Limited a Manager of Parkway Life Real Estate Investment Trust since November 17, 2023. He serves as Vice Chairman of the Bo...

리더십 팀

이름	위치	테뉴어	보상	소유권
Prem Kumar Nair	Group Chief Executive Officer	1.1yrs	데이터 없음	데이터 없음
Dilip Kadambi	Group Chief Financial Officer	less than a year	데이터 없음	데이터 없음
Penelope Koh	Vice President of Investor Relations	no data	데이터 없음	데이터 없음
Nili Shayrina Saat	Group Head of Risk Management & Compliance	1.8yrs	데이터 없음	데이터 없음
Ida binti Ab Rahim	Group General Counsel	5.4yrs	데이터 없음	데이터 없음
Stephen Byrne	Group Head of Internal Audit	3.8yrs	데이터 없음	데이터 없음
Ashok Pandit	Group Chief Corporate Officer	3.3yrs	데이터 없음	데이터 없음
Jean-Francois Naa	Chief Executive Officer of HH Healthcare Malaysia	4.7yrs	데이터 없음	데이터 없음
Anurag Yadav	Chief Executive Officer of IHH Healthcare India	2.8yrs	데이터 없음	데이터 없음
Chorng Ann Chow	Chief Executive Officer of IHH Healthcare Singapore	1.1yrs	데이터 없음	데이터 없음
Kenneth Tsang	Regional Chief Executive Officer of IHH Healthcare North Asia	no data	데이터 없음	데이터 없음
Ching Seow	Company Secretary	no data	데이터 없음	데이터 없음

2.8yrs

평균 재임 기간

53yo

평균 연령

경험이 풍부한 관리: Q0F 의 관리팀은 경험 ( 2.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Nik Norzrul Bin Nik Hassan Thani	Independent Non-Executive Chairman	less than a year	데이터 없음	데이터 없음
Muthanna Bin Abdullah	Independent Non-Executive Director	no data	RM 674.00k	데이터 없음
Satoshi Tanaka	Independent Non-Executive Director	no data	RM 499.00k	데이터 없음
Mehmet Aydinlar	Non-Independent & Non-Executive Director	12.8yrs	RM 399.00k	0.17% SGD 31.7m
Jill Watts	Independent Non-Executive Director	no data	RM 674.00k	데이터 없음
Tomo Nagahiro	Non-Independent & Non-Executive Director	1.8yrs	RM 361.00k	데이터 없음
Tsin-Lin Lim	Non Independent Non Executive Director	1.8yrs	데이터 없음	데이터 없음
Jia Mok	Non Independent & Non Executive Alternate Director	1.8yrs	데이터 없음	데이터 없음

1.8yrs

평균 재임 기간

63.5yo

평균 연령

경험이 풍부한 이사회: Q0F 의 이사회는 경험(평균 재직 기간 1.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.

IHH Healthcare Berhad 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces the Appointment of Chua Bin Hwee as Independent and Non Executive Director, Effective August 14, 2024

IHH Healthcare Berhad Appoints Tan Sri Dr. Nik Norzrul Thani Bin N. Hassan Thani as Independent and Non Executive Chairman

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

High number of new directors

Recent updates

IHH Healthcare Berhad to Report Q3, 2024 Results on Nov 28, 2024

Upcoming dividend of RM0.045 per share

First half dividend of RM0.045 announced

IHH Healthcare Berhad Declares Interim Single Tier Cash Dividend for the Financial Year Ending 31 December 2024, Payable on October 30, 2024

Second quarter 2024 earnings released: EPS: RM0.071 (vs RM0.034 in 2Q 2023)

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces the Appointment of Chua Bin Hwee as Independent and Non Executive Director, Effective August 14, 2024

IHH Healthcare Berhad to Report Q2, 2024 Results on Aug 30, 2024

IHH Healthcare Berhad Appoints Tan Sri Dr. Nik Norzrul Thani Bin N. Hassan Thani as Independent and Non Executive Chairman

New minor risk - Earnings quality

First quarter 2024 earnings released: EPS: RM0.087 (vs RM0.16 in 1Q 2023)

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

IHH Healthcare Berhad to Report Q1, 2024 Results on May 29, 2024

High number of new directors

IHH Healthcare Berhad, Annual General Meeting, May 28, 2024

IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer

Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024

Upcoming dividend of RM0.055 per share

Dividend of RM0.055 announced

Full year 2023 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad to Report Q4, 2023 Results on Feb 29, 2024

IHH Healthcare Berhad Announces Cessation of Joerg Ayrle as Chief Financial Officer

Third quarter 2023 earnings released: EPS: RM0.06 (vs RM0.028 in 3Q 2022)

IHH Healthcare Berhad to Report Q3, 2023 Results on Nov 30, 2023

IHH Healthcare Berhad Announces Joerg Ayrle, Group Chief Financial Officer to Remain on Garden Leave, Effective from 30 September 2023

Upcoming dividend of RM0.035 per share at 1.2% yield

IHH Healthcare Berhad Declares Interim Dividend, Payable on October 27, 2023

Second quarter 2023 earnings released: EPS: RM0.034 (vs RM0.067 in 2Q 2022)

IHH Healthcare Berhad to Report Q2, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: RM0.16 (vs RM0.054 in 1Q 2022)

Upcoming dividend of RM0.096 per share at 1.2% yield

IHH Healthcare Berhad to Report Q1, 2023 Results on May 31, 2023

IHH Healthcare Berhad Announces Special Cash Dividend, Payable on 30 June 2023

High number of new directors

Upcoming dividend of RM0.07 per share at 1.2% yield

Full year 2022 earnings released: EPS: RM0.17 (vs RM0.20 in FY 2021)

IHH Healthcare Berhad Announces Appointment of Mr. Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces Resignation of Farid Bin Mohamed Sani as Non Independent and Non Executive Director

IHH Healthcare Berhad Appoints Tomo Nagahiro as Non-Independent and Non-Executive Director

IHH Healthcare Berhad to Report Q4, 2022 Results on Feb 28, 2023

IHH Healthcare Berhad Announces the Resignation of Tomo Nagahiro as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad Announces the Cessation of Takeshi Saito as Member of Nomination and Remuneration Committee, Effective January 27, 2023

Third quarter 2022 earnings released: EPS: RM0.028 (vs RM0.06 in 3Q 2021)

IHH Healthcare Berhad to Report Q3, 2022 Results on Nov 29, 2022

United States Federal District Court Grants IHH Healthcare Berhad Motion to Dismiss Emqore Amended Complaint

Second quarter 2022 earnings released: EPS: RM0.067 (vs RM0.053 in 2Q 2021)

IHH Healthcare Berhad Reports Write Offs for the Second Quarter Ended June 30, 2022

IHH Healthcare Berhad to Report Q2, 2022 Results on Aug 25, 2022

TPG Capital, L.P. and Hong Leong Group Malaysia agreed to acquire 100% of IMU Health Sdn Bhd from IHH Healthcare Berhad (KLSE:IHH) for a total enterprise value of MYR 1345 million.

TPG Capital, L.P. and Hong Leong Group Malaysia agreed to acquire 100% of IMU Health Sdn Bhd from IHH Healthcare Berhad (KLSE:IHH) for MYR 1345 million.

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

IHH Healthcare Berhad to Report Q1, 2022 Results on May 26, 2022

Now 20% undervalued

High number of new directors

Now 22% undervalued after recent price drop

Permodalan Nasional Reportedly Looking to Dispose of A Portion of Its Shares in IHH Healthcare and Petronas Chemicals Group

IHH Healthcare Berhad Provides Update on Material Litigation

Upcoming dividend of RM0.06 per share

Full year 2021 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad Reports Impairment for the Fourth Quarter Ended December 31, 2021

IHH Healthcare Berhad Announces the Resignation of Wong Eugene as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad to Report Q4, 2021 Results on Feb 24, 2022

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Fortis Healthcare Limited Updates on Its Complaint

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

Second quarter 2021 earnings released: EPS RM0.053 (vs RM0.016 loss in 2Q 2020)